
|Videos|November 24, 2020
Chief Endpoints and Potential Significance: Phase 3b OLIKOS Trial
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA PDUFA Watch: Neurology Decisions to Track Through Late September
2
FDA Clears VoxNeuro's EEG-Based Cognitive Assessment Software
3
Favorable Phase 1 Data for Orexin-2 Agonist BP-205, Broader Pipeline Progress Headline Harmony's Q2 Update
4
Exploring Neprilysin and Amyloid-Beta–Tau Axes in Alzheimer Disease
5
































